376 related articles for article (PubMed ID: 28356729)
1. Measures of bronchodilator response of FEV
Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
[TBL] [Abstract][Full Text] [Related]
2. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
[TBL] [Abstract][Full Text] [Related]
3. Bronchodilator response of advanced lung function parameters depending on COPD severity.
Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
[TBL] [Abstract][Full Text] [Related]
5. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
[TBL] [Abstract][Full Text] [Related]
6. Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population aged 50-64 years - the SCAPIS pilot study.
Torén K; Murgia N; Olin AC; Hedner J; Brandberg J; Rosengren A; Bergström G
Int J Chron Obstruct Pulmon Dis; 2017; 12():2269-2275. PubMed ID: 28831247
[TBL] [Abstract][Full Text] [Related]
7. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
8. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
Chhabra SK; Bhatnagar S
Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
[TBL] [Abstract][Full Text] [Related]
10. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
[TBL] [Abstract][Full Text] [Related]
11. Bronchodilator reversibility in asthma and COPD: findings from three large population studies.
Janson C; Malinovschi A; Amaral AFS; Accordini S; Bousquet J; Buist AS; Canonica GW; Dahlén B; Garcia-Aymerich J; Gnatiuc L; Kowalski ML; Patel J; Tan W; Torén K; Zuberbier T; Burney P; Jarvis D
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31221806
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilator responsiveness and reported respiratory symptoms in an adult population.
Tan WC; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Aaron S; Marciniuk DD; Maltais F; Buist AS; O'Donnell DE; Sin DD;
PLoS One; 2013; 8(3):e58932. PubMed ID: 23554960
[TBL] [Abstract][Full Text] [Related]
13. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
Richter DC; Joubert JR; Nell H; Schuurmans MM; Irusen EM
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):693-9. PubMed ID: 19281083
[TBL] [Abstract][Full Text] [Related]
15. Ratio of FEV
Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
[TBL] [Abstract][Full Text] [Related]
16. Second-order Texture Measurements of (3)He Ventilation MRI: Proof-of-concept Evaluation of Asthma Bronchodilator Response.
Zha N; Pike D; Svenningsen S; Capaldi DP; McCormack DG; Parraga G
Acad Radiol; 2016 Feb; 23(2):176-85. PubMed ID: 26601971
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
Mahler DA; Waterman LA; Ward J; Gifford AH
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
[TBL] [Abstract][Full Text] [Related]
18. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
[TBL] [Abstract][Full Text] [Related]
19. [Spirometric reversibility to salbutamol in chronic obstructive pulmonary disease (COPD). Differential effects on FEV1 and on lung volumes].
Manríquez J; Díaz O; Borzone G; Lisboa C
Rev Med Chil; 2004 Jul; 132(7):787-93. PubMed ID: 15379324
[TBL] [Abstract][Full Text] [Related]
20. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
